AngioDynamics
ANGO
130 hedge funds and large institutions have $492M invested in AngioDynamics in 2016 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 66 increasing their positions, 28 reducing their positions, and 8 closing their positions.
63,800% more call options, than puts
Call options by funds: $639K | Put options by funds: $1K
136% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 28
125% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 8
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
34% more capital invested
Capital invested by funds: $366M → $492M (+$125M)
8% more funds holding
Funds holding: 120 → 130 (+10)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$18.2M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.14M |
| 3 |
Millennium Management
New York
|
+$4.03M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$3.07M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$2.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$11.6M |
| 2 |
RC
RGM Capital
Naples,
Florida
|
-$11.1M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$1.86M |
| 4 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$1.36M |
| 5 |
ACM
American Capital Management
New York
|
-$1.21M |
ANGO Hedge Fund Activity: Q3 2016 in Review
130 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q3 2016, worth a combined $492M — up 34% from $366M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new ANGO positions and 8 closed out — a net gain of 10 holders — while 66 added to existing stakes and 28 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $18.2M. The largest seller was Broadfin Capital, cutting an estimated $11.6M.
- 130 institutional investors held AngioDynamics (ANGO) as of Q3 2016, up from 120 in Q2 2016.
- Funds reported $492M of AngioDynamics stock for Q3 2016, up 34% quarter-over-quarter.
- 18 funds opened new AngioDynamics positions in Q3 2016 and 8 closed out, a net change of +10 holders.
- The largest AngioDynamics buyer in Q3 2016 was Fidelity Investments, an estimated $18.2M added.
- The largest AngioDynamics seller in Q3 2016 was Broadfin Capital, an estimated $11.6M sold.
Based on aggregated 13F filings for Q3 2016.